Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, ...
Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...
Colossal Biosciences raises $200 million, valued at $10.2 billion. Animal Capital's $400,000 investment now worth $50 million ...
The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help ...
The life-sized woolly mammoth fossil sitting inside the Natural History Society of Maryland has the wow factor for those who ...
GUAC is Manuel’s response to his overwhelming grief, his love for his son, and his call to be an activist fighting for gun ...
“But tomorrow it’ll be causing economic effects.” Perhaps known best for its efforts to bring back the woolly mammoth, Dallas-based Colossal’s core mission is preserving biodiversity ...
India's rich biodiversity offers unique opportunities for Colossal Biosciences to revive extinct species like the woolly ...